Skip to Content
Top

BY Scott Merville

Patients in a first-of-its-kind clinical trial will receive a vastly expanded dose of their own T cells — white blood cells that are the specialized warriors of the immune system — followed by a cancer immunotherapy drug known to promote the activation and survival of T cells.

“We’re excited about this combination because there’s no standard of care now for our metastatic melanoma patients if immune checkpoint blockade drugs fail...

Rodabe Amaria, M.D.

BY Ron Gilmore

The 90 percent of cancer patients who experience pain due to nerve damage caused by tumors, surgery, chemotherapy or radiation may someday...

BY Ron Gilmore

Researchers have reported results of the first-ever phase II clinical trial results for treatment with the immunotherapy drug nivolumab on...

BY Ron Gilmore

Receptors for leptin, a protein hormone, may be associated with tumor recurrence in patients with renal cell carcinoma (RCC), providing further understanding about molecular links between obesity and RCC tumor formation and prognosis, according to a MD Anderson study.

The leptin receptors, called LEPR, were found to be hypermethylated in tumors in study participants. Methylation is a process by which cells control gene expression...

BY Sarah Watson

Eight of MD Anderson Cancer Center's top young researchers have been named Andrew Sabin Family Fellows and will receive $100,000 over two...

BY Ron Gilmore

Researchers at MD Anderson Cancer Center have announced a new method for detecting DNA mutations in a single cancer cell versus current technology...

BY Clayton Boldt, Ph.D.

The Affordable Care Act (ACA) was signed into law in 2010 to improve access to affordable health coverage for Americans, and a major focus...

BY Ron Gilmore

The drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined cancer, according to a new MD...

BY Clayton Boldt, Ph.D.

MD Anderson Cancer Center fully supports new rules recently issued by the Food and Drug Administration (FDA) to extend federal regulatory...

BY Laura Sussman

Long associated with liver cancer and non-Hodgkin’s lymphoma, the hepatitis C virus (HCV) for the first time has been associated with certain...